Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 6/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 8/20 | 0.40 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 4/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.38 |
| ▸ | SDHA | P31040 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CALML3 | P27482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23991986 | 1.00 | MAOB (0.41) | MAOBGRM2F10MAOAPTGS1 | |
| SCHEMBL23992008 | 0.91 | MAOB (0.46) | MAOBF10MAOAPTGS1SDHA | |
| SCHEMBL23991995 | 0.91 | MAOB (0.43) | MAOBF10MAOAPTGS1SDHA | |
| SCHEMBL23991985 | 0.91 | MAOB (0.43) | MAOBF10MAOAPTGS1SDHA | |
| SCHEMBL23992005 | 0.89 | MAOB (0.44) | MAOBF10MAOAPTGS1SDHA | |
| SCHEMBL23992007 | 0.86 | MAOB (0.42) | MAOBF10MAOAPTGS1SDHA | |
| SCHEMBL17032463 | 0.85 | MAOB (0.55) | MAOBGRM2F10MAOAPTGS1 | |
| SCHEMBL17039430 | 0.85 | MAOB (0.55) | MAOBGRM2F10MAOAPTGS1 | |
| SCHEMBL23716997 | 0.84 | MAOB (0.44) | MAOBGRM2F10MAOAPTGS1 | |
| SCHEMBL23716992 | 0.84 | MAOB (0.44) | MAOBGRM2F10MAOAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3107923-B1 | WATER-SOLUBLE O-CARBONYL PHOSPHORAMIDATE PRODRUGS FOR THERAPEUTIC ADMINISTRATION | SHANGHAI MICURX PHARMACEUTICAL CO LTD (CN) | 2021-11-03 | — | — | EP | disclosed |